Invaio adds industry leaders from nutrition, biotechnology and artificial intelligence to their Board of Directors to help expedite the adoption of a more mindful approach to feeding ourselves while rejuvenating the planet.



CAMBRIDGE, Mass., Nov. 18, 2020 /PRNewswire/ — Invaio Sciences, Inc., a Flagship Pioneering company focused on unlocking the potential of the planet’s interdependent natural systems to solve pressing agriculture, nutrition and environmental challenges, announces today the appointment of three new industry leading members to its Board of Directors.  Dr. Pietro Antonio Tataranni is Chief Medical Officer at PepsiCo, Ena Cratsenburg is the Chief Business Officer at Ginkgo Bioworks, and Dr. Iya Khalil is Global Head of the AI Innovation Center at Novartis, each adding unique insights to Invaio’s mission to make new discoveries by investigating nature.
Invaio is a multi-platform technology company developing integrated solutions that unlock the potential of our planet’s interdependent natural systems.  Results from this exploration into nature inspire solutions to pressing problems in food, its production, our health and that of the planet.  Combining the knowledge gained from natural systems with groundbreaking technologies from life science and human therapeutics, Invaio is building new platforms that revolutionize plant health care solutions, redefine insect management and instigate regenerative natural resource management.
“It’s a wonderful opportunity for us to work closely with such high caliber leaders in food and science,” explains Dr. Robert Berendes, Invaio’s Chairman of the Board.  “Each new board member brings a wealth of knowledge that will help Invaio continue to develop new technologies in our effort to evolve the production of food and help to stabilize a planet under threat.  With Dr. Khalil’s impressive accomplishments as a scientist and entrepreneur, Ena Cratsenburg’s track record in commercialization and …